ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 6 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,829 | +40.6% | 55,500 | +50.8% | 0.01% | +33.3% |
| Q2 2023 | $6,989 | -51.3% | 36,800 | -48.6% | 0.01% | -53.8% |
| Q1 2023 | $14,342 | +0.9% | 71,600 | +19.7% | 0.01% | -13.3% |
| Q4 2022 | $14,211 | -99.7% | 59,800 | +142.1% | 0.02% | +150.0% |
| Q3 2022 | $4,943,000 | +64.5% | 24,700 | +19.9% | 0.01% | +100.0% |
| Q2 2022 | $3,004,000 | -28.4% | 20,600 | -19.8% | 0.00% | -25.0% |
| Q1 2022 | $4,196,000 | -26.8% | 25,700 | -24.0% | 0.00% | -33.3% |
| Q4 2021 | $5,731,000 | +0.5% | 33,800 | +0.6% | 0.01% | +20.0% |
| Q3 2021 | $5,703,000 | +0.4% | 33,600 | +0.3% | 0.01% | 0.0% |
| Q2 2021 | $5,678,000 | +140.9% | 33,500 | +19959.9% | 0.01% | +25.0% |
| Q1 2021 | $2,357,000 | +74.5% | 167 | +60.6% | 0.00% | +100.0% |
| Q4 2020 | $1,351,000 | -70.4% | 104 | -66.9% | 0.00% | -66.7% |
| Q3 2020 | $4,571,000 | -8.4% | 314 | -6.8% | 0.01% | -25.0% |
| Q2 2020 | $4,991,000 | -35.1% | 337 | -52.3% | 0.01% | -42.9% |
| Q1 2020 | $7,695,000 | -29.7% | 707 | -25.7% | 0.01% | -41.7% |
| Q4 2019 | $10,952,000 | +161.9% | 951 | +82.9% | 0.02% | +100.0% |
| Q3 2019 | $4,181,000 | +249.3% | 520 | +215.2% | 0.01% | +300.0% |
| Q2 2019 | $1,197,000 | -65.7% | 165 | -55.8% | 0.00% | -70.0% |
| Q1 2019 | $3,485,000 | +38.2% | 373 | +7.8% | 0.01% | +42.9% |
| Q4 2018 | $2,522,000 | -30.9% | 346 | -17.0% | 0.01% | -41.7% |
| Q3 2018 | $3,649,000 | +689.8% | 417 | +787.2% | 0.01% | +500.0% |
| Q2 2018 | $462,000 | +173.4% | 47 | -49.5% | 0.00% | -71.4% |
| Q1 2018 | $169,000 | +238.0% | 93 | -46.9% | 0.01% | +250.0% |
| Q4 2017 | $50,000 | -27.5% | 175 | -81.0% | 0.00% | -33.3% |
| Q3 2017 | $69,000 | +115.6% | 922 | +219.0% | 0.00% | +200.0% |
| Q2 2017 | $32,000 | +23.1% | 289 | +301.4% | 0.00% | 0.0% |
| Q1 2017 | $26,000 | -62.9% | 72 | -57.4% | 0.00% | -75.0% |
| Q4 2016 | $70,000 | +169.2% | 169 | -28.1% | 0.00% | +100.0% |
| Q3 2016 | $26,000 | -72.6% | 235 | +9.8% | 0.00% | -66.7% |
| Q2 2016 | $95,000 | +6.7% | 214 | -5.7% | 0.01% | -14.3% |
| Q1 2016 | $89,000 | -22.6% | 227 | +215.3% | 0.01% | -22.2% |
| Q4 2015 | $115,000 | -37.5% | 72 | -1.4% | 0.01% | -30.8% |
| Q3 2015 | $184,000 | +982.4% | 73 | +128.1% | 0.01% | +1200.0% |
| Q2 2015 | $17,000 | -19.0% | 32 | -57.3% | 0.00% | -50.0% |
| Q1 2015 | $21,000 | +320.0% | 75 | +1150.0% | 0.00% | +100.0% |
| Q4 2014 | $5,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 50,000 | $7,293,000 | 0.42% |
| GROUP ONE TRADING, L.P. | 160,100 | $23,351,000 | 0.04% |
| JANE STREET GROUP, LLC | 271,600 | $39,613,000 | 0.02% |
| SIMPLEX TRADING, LLC | 20,600 | $3,004,000 | 0.00% |
| Twin Tree Management, LP | 3,600 | $525,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 11,900 | $1,736,000 | 0.00% |